RIPK3 and acute myeloid leukemia: A typical example is that in patients with acute myeloid leukemia (AML), the expression level of RIP3 decreases, which inhibits the differentiation and apoptosis of hematopoietic cells, which is closely related to the occurrence of AML [19].